Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin
Clinical trial NCT00135096 · COMPLETED
Trial details
- NCT number
- NCT00135096
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.